AMERICAN CENTURY COMPANIES INC - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 7 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2022. The put-call ratio across all filers is 3.11 and the average weighting 1.6%.

Quarter-by-quarter ownership
AMERICAN CENTURY COMPANIES INC ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$43,509,000
+56.3%
287,812
+50.7%
0.04%
+65.2%
Q2 2022$27,835,000
-65.7%
191,031
-72.1%
0.02%
-58.9%
Q1 2022$81,201,000
+209.2%
684,834
+259.4%
0.06%
+229.4%
Q4 2021$26,261,000
-32.2%
190,559
-31.6%
0.02%
-37.0%
Q3 2021$38,725,000
+112.5%
278,776
+48.5%
0.03%
+125.0%
Q2 2021$18,224,000
+43.3%
187,725
+0.9%
0.01%
+33.3%
Q1 2021$12,715,000
-21.4%
186,029
-1.4%
0.01%
-30.8%
Q4 2020$16,170,000
+39.7%
188,658
+5.9%
0.01%
+30.0%
Q3 2020$11,576,000
+5.4%
178,067
+18.5%
0.01%0.0%
Q2 2020$10,985,000
+325.9%
150,256
+98.3%
0.01%
+233.3%
Q1 2020$2,579,000
+67.0%
75,790
+32.5%
0.00%
+50.0%
Q4 2017$1,544,000
+12.3%
57,216
+55.6%
0.00%
+100.0%
Q3 2017$1,375,000
-2.5%
36,772
-34.8%
0.00%0.0%
Q2 2017$1,410,00056,3900.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q4 2022
NameSharesValueWeighting ↓
RP Management, LLC 1,111,111$154,344,00072.03%
Knoll Capital Management, LLC 856,844$119,024,00059.36%
ORACLE INVESTMENT MANAGEMENT INC 2,124,055$295,053,00036.73%
ARS Investment Partners, LLC 466,668$64,825,0006.49%
KINGDON CAPITAL MANAGEMENT, L.L.C. 365,373$50,754,0006.18%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 176,400$24,490,0005.91%
SILVERARC CAPITAL MANAGEMENT, LLC 61,897$8,598,0004.86%
DAFNA Capital Management LLC 88,100$12,238,0003.25%
Avidity Partners Management LP 934,200$129,770,0002.88%
Eventide Asset Management 1,325,000$184,056,0002.43%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders